Format

Send to

Choose Destination
Nat Commun. 2018 Feb 16;9(1):707. doi: 10.1038/s41467-018-03157-4.

Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation.

Author information

1
Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA.
2
Siolta Therapeutics, 953 Indiana Street, San Francisco, CA, 94107, USA.
3
Janssen Prevention Center, 2 Royal College Street, London, NW1 0NH, UK.
4
Division of General Pediatrics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, 94143, USA.
5
Genentech, 340 Pt. San Bruno Boulevard, South San Francisco, CA, 94080, USA.
6
Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, 94143, USA.
7
Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA. susan.lynch@ucsf.edu.

Abstract

Gut microbiota dysbiosis and metabolic dysfunction in infancy precedes childhood atopy and asthma development. Here we examined gut microbiota maturation over the first year of life in infants at high risk for asthma (HR), and whether it is modifiable by early-life Lactobacillus supplementation. We performed a longitudinal comparison of stool samples collected from HR infants randomized to daily oral Lactobacillus rhamnosus GG (HRLGG) or placebo (HRP) for 6 months, and healthy (HC) infants. Meconium microbiota of HRP participants is distinct, follows a delayed developmental trajectory, and is primarily glycolytic and depleted of a range of anti-inflammatory lipids at 6 months of age. These deficits are partly rescued in HRLGG infants, but this effect was lost at 12 months of age, 6 months after cessation of supplementation. Thus we show that early-life gut microbial development is distinct, but plastic, in HR infants. Our findings offer a novel strategy for early-life preventative interventions.

PMID:
29453431
PMCID:
PMC5816017
DOI:
10.1038/s41467-018-03157-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center